An estimated 188,000 Canadians will be diagnosed with cancer this year and as our population ages that number is expected to increase. Mount Sinai Hospital has attracted top international cancer researcher Dr. Daniel Schramek to fulfill the role of Kierans/Janigan Cancer Research Scientist at the Lunenfeld-Tanenbaum Research Institute, part of the Sinai Health System.
Ontario healthcare innovator, MolecuLight Inc., is developing a hand-held optical imaging technology designed to visualize bacteria in real-time at the point-of-care. Founded by Dr. Ralph DaCosta, Scientist at The Princess Margaret Cancer Centre and Techna Institutute, MolecuLight’s device is revolutionizing wound care and strengthening Ontario’s role as a global innovation leader in health care.
In the spring of 2014, Gretta Hutton was diagnosed with Mantle Cell Lymphoma and given 2 – 5 years to live. After weeks of feeling hopeless, she found a clinical trial at Hamilton Health Sciences led by Dr. Tom Kouroukis. One year later, with her cancer in full remission, Gretta sat down with Catalyst to […]